Novus Biotechnology Fund

Venture Capital Firm

Novus Biotechnology Fund

Novus Biotechnology Fund 1 is an investment partnership with offices in Kalamazoo, Michigan and suburban Chicago. The purpose of the targeted $10 million fund is to achieve significant, long-term capital appreciation for its investors through investments in early stage biotech companies. The fund will focus on innovative solutions having a positive economic impact on health care expenditures; technologies which will not only have clinical utility but ultimately lower healthcare costs for the system as a whole.



  • Frank Saltiel, MD
    General Partner, Novus Biotechnology Fund
  • Greg Schultz
    General Partner, Novus Biotechnology Fund
  • Kevin McLeod
    Managing Director, OOB Michigan Medical Device Consortium

Stages of Investment


Sectors of Investment

  • n/a

IT Subsectors

Life Science Subsectors

The most timely & relevant email you will get about Michigan’s investment & entrepreneurial ecosystem.

From public policy to the new ideas and breakthrough investment opportunities, MVCA will keep your finger on the pulse of must know information in the industry.


This field is for validation purposes and should be left unchanged.